Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Decision making about healthcare-related tests and diagnostic test strategies: what "The death of Ivan Ilyich" teaches us.

Duarte PS.

J Clin Epidemiol. 2019 Jun;110:97-98. doi: 10.1016/j.jclinepi.2019.02.006. Epub 2019 Feb 14. No abstract available.

PMID:
30772454
2.

18F-Fluoride Uptake in Soft Tissue Metastases of Medullary Thyroid Carcinoma as a Marker of Progressive Calcification.

Duarte PS, Marin JFG, Filho GBC, Sapienza MT, Buchpiguel CA.

Clin Nucl Med. 2018 Nov;43(11):848-849. doi: 10.1097/RLU.0000000000002259.

PMID:
30179909
3.

Comparison of the Variability of SUV Normalized by Skeletal Volume with the Variability of SUV Normalized by Body Weight in 18F-Fluoride PET/CT.

Gomes Marin JF, Duarte PS, Willegaignon de Amorim de Carvalho J, Sado HN, Sapienza MT, Buchpiguel CA.

J Nucl Med Technol. 2019 Mar;47(1):60-63. doi: 10.2967/jnmt.118.215111. Epub 2018 Aug 23.

PMID:
30139886
4.

Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on 18F-Fluoride PET/CT than on 68Ga-Dotatate PET/CT.

Duarte PS, de Castroneves LA, Sado HN, Sapienza MT, de Oliveira Hoff AAF, Buchpiguel CA.

Nucl Med Mol Imaging. 2018 Aug;52(4):318-323. doi: 10.1007/s13139-018-0527-8. Epub 2018 Jun 4.

PMID:
30100945
5.

Brain Metastasis of Medullary Thyroid Carcinoma Without Macroscopic Calcification Detected First on 68Ga-Dotatate and Then on 18F-Fluoride PET/CT.

Duarte PS, Marin JFG, De Carvalho JWA, Sapienza MT, Buchpiguel CA.

Clin Nucl Med. 2018 Aug;43(8):623-624. doi: 10.1097/RLU.0000000000002163.

PMID:
29894334
6.

Bone marrow uptake of 18F-fluorodeoxyglucose in Hodgkin lymphoma without bone involvement: comparison between patients with and without B symptoms.

do Vale RHB, Ferraro DA, Duarte PS, Carvalho G, Lima MS, Coura Filho GB, Sapienza MT, Buchpiguel CA.

Radiol Bras. 2018 Mar-Apr;51(2):76-80. doi: 10.1590/0100-3984.2016.0201.

7.

Iodine/FDG "Flip-Flop" Phenomenon Inside a Large Metastatic Thyroid Cancer Lesion Better Characterized on SPECT/CT and PET/CT Studies.

Duarte PS, Marin JFG, de Carvalho JWA, Sapienza MT, Buchpiguel CA.

Clin Nucl Med. 2018 Jun;43(6):436-438. doi: 10.1097/RLU.0000000000002046.

PMID:
29517543
8.

Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer.

Braghiroli MI, Mota JM, Duarte PS, Morita TO, Bariani GM, Nebuloni D, Buchpiguel CA, Hoff PM, Riechelmann RP.

Nucl Med Commun. 2018 Mar;39(3):252-259. doi: 10.1097/MNM.0000000000000810.

PMID:
29381586
9.

Complementary findings on 18F-FDG PET/CT and 18F-NaF PET/CT in a patient with Erdheim-Chester disease.

Sabino D, do Vale RHB, Duarte PS, Sapienza MT, Buchpiguel CA.

Radiol Bras. 2017 May-Jun;50(3):202-203. doi: 10.1590/0100-3984.2015.0172. No abstract available.

10.

Incidental diagnosis of struma ovarii through radioiodine whole-body scanning: incremental role of SPECT/CT.

do Vale RH, Sado HN, Danilovic DL, Duarte PS, Sapienza MT.

Radiol Bras. 2016 Mar-Apr;49(2):126-7. doi: 10.1590/0100-3984.2015.0027. No abstract available.

11.

SUV Normalized by Skeletal Volume on 18F-Fluoride PET/CT Studies.

Carvalho G, Marin JF, Garcez AT, Duarte PS, Sapienza MT, Buchpiguel CA.

Clin Nucl Med. 2016 Jul;41(7):529-33. doi: 10.1097/RLU.0000000000001221.

PMID:
27055138
12.

Receiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT.

Valadares AA, Duarte PS, Carvalho G, Ono CR, Coura-Filho GB, Sado HN, Sapienza MT, Buchpiguel CA.

Radiol Bras. 2016 Jan-Feb;49(1):12-6. doi: 10.1590/0100-3984.2014.0119.

13.

Preliminary Comparison of PET/CT Studies Performed After Intravenous and Oral Administration of 18F-Fluoride.

Zacchi SR, do Vale RH, Duarte PS, Sapienza MT, Buchpiguel CA.

Clin Nucl Med. 2016 Jan;41(1):79-80. doi: 10.1097/RLU.0000000000001057.

PMID:
26545027
14.

Visualization of Lymph Nodal and Hepatic Metastases of Medullary Thyroid Carcinoma on 18F-Fluoride PET/CT.

do Vale RH, Marin JF, Duarte PS, Sapienza MT, Buchpiguel CA.

Clin Nucl Med. 2015 Nov;40(11):895-6. doi: 10.1097/RLU.0000000000000939.

PMID:
26444649
15.

Clinical and Dosimetric Variables Related to Outcome After Treatment of Graves' Disease With 550 and 1110 MBq of 131I: Results of a Prospective Randomized Trial.

Sapienza MT, Coura-Filho GB, Willegaignon J, Watanabe T, Duarte PS, Buchpiguel CA.

Clin Nucl Med. 2015 Sep;40(9):715-9. doi: 10.1097/RLU.0000000000000840.

PMID:
26204202
16.

Prevalence of exclusive lower extremity metastases at (18)F-NaF PET/CT.

Ordones MB, Valadares AA, Duarte PS, Sado HN, Lima MS, Carvalho G, Sapienza MT, Buchpiguel CA.

Radiol Bras. 2015 May-Jun;48(3):143-7. doi: 10.1590/0100-3984.2014.0053.

17.

Comparison of standardized uptake values measured on F-NaF PET/CT scans using three different tube current intensities.

Valadares AA, Duarte PS, Woellner EB, Coura-Filho GB, Sapienza MT, Buchpiguel CA.

Radiol Bras. 2015 Jan-Feb;48(1):17-20. doi: 10.1590/0100-3984.2014.0034.

19.

PET/CT study performed after an oral administration of 18F-fluoride.

Zacchi SR, Valadares AA, Duarte PS, Sapienza MT, Buchpiguel CA.

Clin Nucl Med. 2013 Dec;38(12):1012-4. doi: 10.1097/RLU.0000000000000250.

PMID:
24152650
20.

Incidental finding of anterior cranial fossa meningioma on 18F-fluoride PET/CT.

Zacchi SR, Duarte PS, Coura Filho GB, Sapienza MT, Buchpiguel CA.

Clin Nucl Med. 2013 Nov;38(11):913-5. doi: 10.1097/RLU.0b013e3182a77c49.

PMID:
24096998

Supplemental Content

Loading ...
Support Center